Approval · Notice of Compliance 31440 · 2023
PEDIAPRED: Notice of Compliance 31440
Issued August 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31440
- Date
- August 18, 2023
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEDIAPRED | Not yet assigned | — |
Medicinal ingredients
- PREDNISOLONE SODIUM PHOSPHATE 5 MG per 5ML